Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains
Rekha G. Panchal,1* Ricky L. Ulrich,1 Douglas Lane,2 Michelle M. Butler,3 Chad Houseweart,3 Timothy Opperman,3 John D. Williams,3 Norton P. Peet,3 Donald T. Moir,3 Tam Nguyen,2 Rick Gussio,4 Terry Bowlin,3 and Sina Bavari1*
United States Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, Maryland 21702-5011,1 Target Structure Based Drug Discovery Group, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland 21702-1201,2 Microbiotix Inc., One Innovation Dr., Worcester, Massachusetts 01605,3Target Structure Based Drug Discovery Group, Information Technology Branch, Developmental Therapeutic Program, National Cancer Institute, Frederick, Maryland 21702-12014
No comments:
Post a Comment